Maximizing cancer synthetic lethality using dual PI-3K/PARP inhibitors
-
Award Number: R41CA206859
-
ORGANIZATION: NATIONAL CANCER INSTITUTE
-
OPDIV: NIH
-
AWARD CLASS: DISCRETIONARY
-
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)